Form 4 for APH Amphenol
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-18 · accession 0001104659-25-080245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $22.37 | +30.0K | 106.4K | +39% | +$671.1K |
| DI | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | S - Sale+OE | $110.81 | -30.0K | 76.4K | -28% | -$3.32M |
| D | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $22.55 | +100.0K | 176.4K | +131% | +$2.25M |
| D | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | S - Sale+OE | $110.60 | -100.0K | 76.4K | -57% | -$11.06M |
| D | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $0.00 | -100.0K | 220.0K | -31% | $0 |
| DI | 2025-08-19 | 2025-08-18 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $0.00 | -30.0K | 40.0K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-08-18 | M | A | 30,000 | $22.37 | 106,400 | I | — | — | |
| 2 | Common | Class A Common Stock | 2025-08-18 | S | D | 30,000 | $110.81 | 76,400 | I | — | — | (F1) The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) This transaction was executed in multiple trades raging from $110.7100 to $110.9300. |
| 3 | Common | Class A Common Stock | 2025-08-18 | M | A | 100,000 | $22.55 | 176,400 | D By Lance E. D'Amico 2024 Irrevocable Trust | — | — | |
| 4 | Common | Class A Common Stock | 2025-08-18 | S | D | 100,000 | $110.60 | 76,400 | D By Lance E. D'Amico 2024 Irrevocable Trust | — | — | (F2) This transaction was executed in multiple trades ranging from $110.5000 to $110.8050. (F1) The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Derivative | Stock Option | 2025-08-18 | M | D | 100,000 | $0.00 | 220,000 | D By Lance E. D'Amico 2024 Irrevocable Trust | $22.55 · 2021-05-21 to 2030-05-21 | 100,000 Class A Common Stock | |
| 6 | Derivative | Stock Option | 2025-08-18 | M | D | 30,000 | $0.00 | 40,000 | I | $22.37 · 2020-05-23 to 2029-05-23 | 30,000 Class A Common Stock |